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Abstract
Primary angiosarcoma of the breast is a rare tumour that account for fewer than 0.05% of all malignant mammary
tumours. Angiosarcoma may have an perfidious clinical onset. Radiologic findings are often nonspecific and may
appear completely normal in one-third of cases with primary angiosarcoma. The prognosis is usually poor because
of the high rates of local recurrence and early development of metastases. Aggressive surgical resection is the
mainstay of treatment. The role of adjuvant therapy has not yet been well established.
Here we present a case of a 53 year old, postmenopausal women with primary angiosarcoma arising in
fibroadenoma. To our knowledge, this is the first case described in the literature to date.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1812981492621981.
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Background
Angiosarcoma is a rare malignancy of endovascular ori-
gin. Skin and superficial soft tissue are the most com-
mon locations that become involved. This is in contrast
with the deeper location of other soft tissue sarcomas.
Less frequently it can occur in various organs and has
been reported in uterus [1], ovary [2], small intestine
[3], lung [4], heart [5], oral cavity [6], orbit [7] and thyr-
oid [8]. Unlike angiosarcomas of the skin, deep angiosar-
comas more commonly have an epitheloid appearance
consisting of nests and clusters of round cells of high
nuclear grade. These so called epitheloid angiosarcomas
consists of sheets of highly atypical round cells with
prominent nuclei, some of which contain intracytoplas-
mic lumens.
Primary soft tissue sarcomas represent fewer than 1%
of primary breast malignancies. Angiosarcomas are rare
and highly aggressive tumours that account for fewer
than 0.05% of all malignant mammary tumours [9].
They may arise spontaneously (as a primary malignancy)
or as a sequel of radiation therapy and postoperative
lymphedema due to breast cancer (secondary). In
comparison, primary angiosarcomas are relatively rarer,
they tipically occurs in younger women and arise from
breast parenchyma. Secondary angiosarcomas usually
occurs in elderly women, arise from skin and show a
pattern of infiltration into breast parenchyma from skin
and subcutis. Both primary and secondary breast angio-
sarcoma carry a prognosis worse than mammary carci-
noma [10]. Synchronous bilateral angiosarcoma has
been reported [11], although the contralateral breast is a
common site of metastasis and such cases may poten-
tially represent metastatic spread. Primary breast angio-
sarcoma has also been described in conjunction with
synchronous primary breast carcinoma [12,13] and also
with silicone granuloma after breast augmentation [14].
Fibroadenomas are the most common benign tumors
of the female breast. They are most frequent in young
women, mainly those under 30 years, but may be seen at
any age. These tumours are characterized by a prolifera-
tion of both stromal and epithelial elements of the breast.
Fibroadenoma may be associated with fibrocystic
changes, calcifications, proliferative epithelial changes,
and extremely rarely, lobular and ductal non-invasive and
invasive carcinoma may occur within fibroadenoma [15].
Angiosarcoma arising in fibroadenoma has not been
documented so far, to the best of our knowledge. Only
one case of angiosarcoma arising in a recurrent
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phyllodes tumor has been published [16]. Here we pre-
sent a case of a 53 year old women with primary angio-
sarcoma arising in fibroadenoma.
Case presentation
A 53-year old postmenopausal female presented with a
lump in the upper outer quadrant of her right breast. At
physical examination a mass was palpable, painless, firm
and not fixed to the underlying structure. There was no
history of pain or nipple discharge. Overlying skin was
unremarkable. The patient had not received any radio-
therapy in the past. Any family history of breast malig-
nancies was denied.
Mammography revealed two well circumscribed nodu-
lar formations in the upper outer quadrant of right
breast. The contours were smooth, with high density
and homogeneous. The conclusion of radiologist was
benign finding (BI-RADS 2).
Ultrasonography revealed macrolobulated complex
formation measuring in diameter 41 mm. The ultraso-
nography guided core needle biopsy was also taken.
Pathologic examination of this sample showed fibroade-
noma (Figure 1).
After 6 months, a lump in breast progressively
increased in size to a size of 80 × 35 mm. The patient
did not complain of tenderness or pain. There was no
history of nipple retraction or discharge. Overlying skin
was unchanged. No axillary or supraclavicular lymph
nodes were palpable. The contralateral breast and axilla
were normal.
Lumpectomy was suggested. On gross examination, the
specimen consisted of a fibrofatty piece of tissue measuring
5 × 5 × 4.5 cm. On sectioning there was a lobulated, partly
soft and hemorrhagic, incapsulated nodule measuring 4 cm
in diameter. Microscopy revealed a tumor to be a
fibroadenoma with pericanalicular and intracanlicular pat-
terns of growth and with stromal hyalinization. Within the
tumor there was one focus composed of marked prolifera-
tion of poorly formed, thin-walled vascular channels lined
with highly atypical endothelial cells. Necrotic foci with
marked hemorrhage and relatively solid proliferation of
polygonally-shaped and spindle atypical endothelial cells
were seen. Prominent tufts and papilations composed of
enlarged, polygonally-shaped, highly malignant endothelial
cells, with brisk mitotic activity, was also observed (Figure
2). The endothelial cells had abundant cytoplasm with
spindle-shaped or round nuclei and showed either a papil-
lary or solid growth pattern. A panel of immunohistochem-
ical markers was performed. The neoplastic endothelium
was diffusely and strongly reactive for CD31. With CD34
immunostain parts of the tumor were strongly positive
(Figure 2), while in poorer differentiated areas, with epithe-
loid and solid appearance almost completely negative. The
neoplastic cells were negative for pan cytokeratin clone
MNF 116 and desmin. In addition, proliferative activity
was determined using monoclonal antibody Ki-67/MIB-1.
Ki-67 proliferative activity in fibroadenoma was 4% and in
part of the lesion with malignant endothelial cells 57% (Fig-
ure 3). A diagnosis of high-grade angiosarcoma arising in
fibroadenoma was made. Radical mastectomy was per-
formed subsequently and no residual tumour was found.
Cysts with epithelial lining showing apocrine metaplasia,
sclerosing adenosis with microcalcifications and additional
fibroadenoma measuring 3 mm in diameter was observed
in the adjacent breast tissue.
The postoperative course was uneventful. After the
operation extensive clinical evaluation was performed to
exclude potential metastatic processes. All test results
were normal. Eight months after the surgery the patient
is free of recurrence and metastasis.
Figure 1 Core needle biopsy specimen of the breast showing fibroadenoma. (HE), 40 × (A), 100 × (B).
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Discussion
Angiosarcoma of the breast, including primary and
secondary type, remain rare malignancy. Although, pri-
mary angiosarcomas may arise at any location in the
body, they rarely arise from major vessels and have a
predilection for skin and supreficial soft tissue. When
it occurs in the breast, it affects women during the
third and fourth decades of life. The etiology of
primary angiosarcoma is still unresolved. Twelve per-
cent of the cases are found during pregnancy, implay-
ing a hormonal effect [17]. In contrary our patient was
slightly older post-menopausal women. There are no
known risk factors for developing primary angiosarco-
mas, but it has been reported adjacent to foreign mate-
rials. There has been a report of development breast
angiosarcoma adjacent to silicone granuloma in a
Figure 2 Microscopic features of the resected tumor. Fibroadenoma of the breast HE, 100 × (A). Fibroadenoma and angiosarcoma in the
same field, HE, 20 × (B). Angiosarcoma, the tumor is highly vascular with relatively solid spindle cell proliferation and area of stromal
hemorrhage, HE, 100 × (C). Prominent tufts and papilations composed of enlarged highly malignant endothelial cells with brisk mitotic activity,
HE, 200 × (D). Immunohistochemical stain for vascular marker CD34 was positive in angiosarcoma and negative in fibroadenoma, 40 × (E). Highly
malignant endothelial cells, HE, 400 × (F).
Figure 3 Immunohistochemical staining with monoclonal antibody Ki-67/MIB-1. Ki-67 proliferative activity in fibroadenoma, 40 × (A); and
in angiosarcoma, 40 × (B).
Babarović et al. Diagnostic Pathology 2011, 6:125
http://www.diagnosticpathology.org/content/6/1/125
Page 3 of 5
patient who underwent breast augmentation with sili-
cone implants [14]. An extuberant host response in the
form of a fibrous tissue capsule around the foreign
material may represent an important intermediate step
in the development of the angiosarcoma. The prog-
nosis of primary angiosarcoma is usually poor because
of the high rates of local recurrence and early develop-
ment of metastases [18]. Angiosarcoma of the breast
has a tendency to metastasize hematogenously, the
regional lymph node involvement is uncommon either
at presentation or at recurrence [19]. The most com-
mon sites of metastasis are lung, bone, liver and skin.
Angiosarcoma may have an perfidious clinical onset,
presenting as a painless often discrete mass that grows
rapidly. Radiologic findings are often nonspecific, and
angiosarcoma may easily be overlooked. Mammograms
may show a nonspecific mass and may appear comple-
tely normal in one-third of cases with primary angio-
sarcoma. Visible masses may be ill-defined or
circumscribed, and may be round to oval or more
lobulated. Associated coarse calcifications may be pre-
sent [20]. Luini et al reported that most authors report
normal mammographic findings in cases of primary
angiosarcoma [9]. Ultrasonography tends to be nonspe-
cific. The diagnosis of primary angiosarcoma of the
breast may be challenging. The main differential diag-
noses of high-grade angiosarcoma are metaplastic car-
cinoma with angiosarcomatous differentiation and
other poorly differentiated sarcomas. Histologically, the
presence of characteristic lower-grade angiosarcoma at
the periphery of the lesion can be helpful in diagnosis.
In our case peripheral parts of tumor were composed
of poorly formed, thin-walled vascular channels lined
with highly atypical endothelial cells. Similarly, meta-
plastic carcinomas may be associated with DCIS or
areas of typical invasive carcinoma of ductal type. The
use of immunohistochemical markers for endothelium,
CD31, CD34 and factor VIII, confirm most angiosarco-
mas including poorly differentiated ones. As in our
case, usually in angiosarcomas CD34 highlights mainly
the uninvolved background vessels, and in fact, there
are different reports that have shown variable reaction
patterns to CD34 ranging from completely negative to
approximately 80% positivity of the neoplastic cells
[21]. In our patient, the intense reaction was seen in
peripheral areas of neoplastic lasion and in uninvolved
vasculature, while in poorer differentiated, solid areas
there was no immunoreactivity with CD34. CD31 is
the most specific marker for endothelial differentiation,
whereas CD34 is more sensitive. In our case a diagno-
sis of high grade angiosarcoma was confirmed by
strong and diffuse positive reaction for CD31, along
with negative cytokeratin and desmin stains. So the
diagnosis of metaplastic carcinoma and possible
combined myovascular lesions were ruled out. More-
over, a Ki-67 proliferative score of 57% along with
marked pleomorphisam of endothelial cells are striking
features in favour of high grade malignancy.
Primary breast angiosarcomas are a heterogeneous
group of lesions histologically, composed of interanasto-
mosing vascular channels lined by hyperchromatic
endothelial cells, occurring within the breast parenchyma.
Angiosarcomas of the breast can be classified into three
main growth patterns, well-differentiared (Grade I) to
poorly differentiated (Grade III) tumors. The cells of the
low grade angisarcoma resemble endothelium, while in
majority of high grade angisarcoma endothelial tufting and
papillary formations are prominent and the endothelial
cells show marked cytological atypia with prominent
nucleoli and frequent mitotic figures as in our case. Hae-
morrhage into the surrounding stroma (“blood lakes”) and
areas of necrosis may be present. However, variations in
growth pattern are commonly found within a single lesion;
in particular, high-grade lesions can have lower-grade
areas at their peripheral and superficial aspects. It was
believed that histologic grade is of prognostic importance,
but a recent study show that there is no correlation
between histologic grade and patients outcome [22]. The
prognostic factors of breast angiosarcoma include the
tumor size, presence of residual disease, cellular pleo-
morphism and proliferative index [23,24]. Aggressive sur-
gical resection is the mainstay of treatment. Even tought
angiosarcoma at other sites often involve regional lymph
nodes [25], in breast angiosarcoma the regional lymph
node involvement is uncommon either at presentation or
at recurrence [19,25,26]. The role of adjuvant therapy with
radiotherapy and chemotherapy has not yet been well
established. A recent study reported a case of complete
response to adjuvant thalidomide therapy [27]. The
aggressive nature of this disease require exploration of
new adjuvant therapy regimens.
Conclusions
The rarity of primary angiosarcoma, unusual presenta-
tion of our case and possible diagnostic pitfalls associated
with poor prognosis emphasizes the need for systemic
presentation of these tumors in order to help pathologists
and clinicians to know that such an entity can initially
present as fibroadenoma. The aggressive nature of this
disease demands careful follow-up of these patients, due
to rarity of the condition the appropriate strategies of
treatment remain to be determined. The question
remains should we consider less aggresive terapeutic
approach for small lesions diagnosed microscopically?
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
Babarović et al. Diagnostic Pathology 2011, 6:125
http://www.diagnosticpathology.org/content/6/1/125
Page 4 of 5
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Author details
1Department of Pathology, School of Medicine, University of Rijeka, Braće
Branchetta 20, Rijeka, Croatia. 2Department of General Surgery, Rijeka
University Hospital Center, Krešimirova 42, Rijeka, Croatia.
Authors’ contributions
EB participated in the design of the study, and drafted the final version of
the manuscript. GZ participated in design of the study and manuscript
drafting, carried out histopathological evaluation. EM participated in
histopathological evaluation and helped in drafting the manuscript. MS
tracked the clinical data and helped in drafting the manuscript.
All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 20 October 2011 Accepted: 20 December 2011
Published: 20 December 2011
References
1. Olawaiye AB, Morgan JA, Goodman A, Fuller AF Jr, Penson RT: Epithelioid
angiosarcoma of the uterus: a review of management. Arch Gynecol
Obstet 2008, 278:401-4.
2. Bösmüller H, Gruber C, Haitchi-Petnehazy S, Wagner D, Webersinke G,
Hauptmann S: Primary angiosarcoma of the ovary with prominent
fibrosis of the ovarian stroma. Case report of an 81-year old patient.
Diagn Pathol 2011, 6:65.
3. Al Ali J, Ko HH, Owen D, Steinbrecher UP: Epithelioid angiosarcoma of the
small bowel. Gastrointest Endosc 2006, 64:1018-21.
4. Pandit SA, Fiedler PN, Westcott JL: Primary angiosarcoma of the lung. Ann
Diagn Pathol 2005, 9:302-4.
5. Uto T, Bando M, Yamauchi H, Nakayama M, Ohata M, Mato N, Nakaya T,
Yamasawa H, Kawai T, Sugiyama Y: Primary cardiac angiosarcoma of the
right auricle with difficult-to-treat bilateral pleural effusion. Intern Med
2011, 50:2371-4.
6. Terada T: Angiosarcoma of the oral cavity. Head Neck Pathol 2011, 5:67-70.
7. Siddens JD, Fishman JR, Jackson IT, Nesi FA, Tsao K: Primary orbital
angiosarcoma: a case report. Ophthal Plast Reconstr Surg 1999, 15:454-9.
8. Isa NM, James DT, Saw TH, Pennisi R, Gough I: Primary angiosarcoma of
the thyroid gland with recurrence diagnosed by fine needle aspiration:
a case report. Diagn Cytopathol 2009, 37:427-32.
9. Luini A, Gatti G, Diaz J, Botteri E, Oliveira E, Cecilio Sahium de Almeida R,
Veronesi P, Intra M, Pagani G, Naninato P, Viale G: Angiosarcoma of the
breast: the experience of the European Institute of Oncology and a
review of the literature. Breast Cancer Res Treat 2007, 105:81-5.
10. Biswas T, Tang P, Muhs A, Ling M: Angiosarcoma of the breast: a rare
clinicopathological entity. Am J Clin Oncol 2009, 32:582-6.
11. Zhou SA, Wei H, Ding K: A Rare Case of Metachronous Bilateral
Angiosarcoma of the Breast. Breast Care (Basel) 2009, 4:405-407.
12. Ryan JF, Kealy WF: Concomitant angiosarcoma and carcinoma of the
breast: a case report. Histopathology 1985, 9:893-9.
13. Tranbaloc P, Lefranc JP, Blondon J, Chomette G: Angiosarcoma of the
breast associated with contralateral carcinoma. Apropos of a case
report. Ann Pathol 1988, 8:67-9.
14. Takenaka M, Tanaka M, Isobe M, Yamaguchi R, Kojiro M, Shirouzu K:
Angiosarcoma of the breast with silicone granuloma: a case report.
Kurume Med J 2009, 56:33-7.
15. Diaz NM, Palmer JO, McDivitt RW: Carcinoma arising within
fibroadenomas of the breast. A clinicopathologic study of 105 patients.
Am J Clin Pathol 1991, 95:614-22.
16. Mamoon N, Mushtaq S, Hassan U, Rashid R, Khadim MT, Sarfraz T,
Waqar MA: Angiosarcoma arising in recurrent phyllodes tumour.
Histopathology 2009, 54:913-6.
17. Barrenetxea G, Schneider J, Tánago JG, Pérez C, Centeno MM, Rodríguez-
Escudero FJ: Angiosarcoma of the breast and pregnancy: a new
therapeutic approach. Eur J Obstet Gynecol Reprod Biol 1995, 60:87-9.
18. Chen KT, Kirkegaard DD, Bocian JJ: Angiosarcoma of the breast. Cancer
1980, 46:368-71.
19. Sher T, Hennessy BT, Valero V, Broglio K, Woodward WA, Trent J, Hunt KK,
Hortobagyi GN, Gonzalez-Angulo AM: Primary angiosarcomas of the
breast. Cancer 2007, 110:173-8.
20. Liberman L, Dershaw DD, Kaufman RJ, Rosen PP: Angiosarcoma of the
breast. Radiology 1992, 183:649-54.
21. Prescott RJ, Banerjee SS, Eyden BP, Haboubi NY: Cutaneous epithelioid
angiosarcoma: a clinicopathological study of four cases. Histopathology
1994, 25:421.
22. Nascimento AF, Raut CP, Fletcher CD: Primary angiosarcoma of the breast:
clinicopathologic analysis of 49 cases, suggesting that grade is not
prognostic. Am J Surg Pathol 2008, 32:1896-904.
23. Zelek L, Llombart-Cussac A, Terrier P, Pivot X, Guinebretiere JM, Le
Pechoux C, Tursz T, Rochard F, Spielmann M, Le Cesne A: Prognostic
factors in primary breast sarcomas: a series of patients with long-term
follow-up. J Clin Oncol 2003, 21:2583-8.
24. Bousquet G, Confavreux C, Magné N, de Lara CT, Poortmans P, Senkus E, de
Lafontan B, Bolla M, Largillier R, Lagneau E, Kadish S, Lemanski C,
Ozsahin M, Belkacémi Y: Outcome and prognostic factors in breast
sarcoma: a multicenter study from the rare cancer network. Radiother
Oncol 2007, 85:355-61.
25. Abraham JA, Hornicek FJ, Kaufman AM, Harmon DC, Springfield DS,
Raskin KA, Mankin HJ, Kirsch DG, Rosenberg AE, Nielsen GP, Desphpande V,
Suit HD, DeLaney TF, Yoon SS: Treatment and outcome of 82 patients
with angiosarcoma. Ann Surg Oncol 2007, 14:1953-67.
26. Monroe AT, Feigenberg SJ, Mendenhall NP: Angiosarcoma after breast-
conserving therapy. Cancer 2003, 97:1832-40.
27. Raina V, Sengar M, Shukla NK, Deo SS, Mohanty BK, Sharma D, Ray R, Das P,
Rath GK: Complete response from thalidomide in angiosarcoma after
treatment of breast cancer. J Clin Oncol 2007, 25:900-1.
doi:10.1186/1746-1596-6-125
Cite this article as: Babarović et al.: High grade angiosarcoma arising in
fibroadenoma. Diagnostic Pathology 2011 6:125.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Babarović et al. Diagnostic Pathology 2011, 6:125
http://www.diagnosticpathology.org/content/6/1/125
Page 5 of 5
